A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Posterior-, or Pan-Uveitis

Clinical trial NCT00404612 · COMPLETED

Trial details

NCT number: NCT00404612
Sponsor: Lux Biosciences, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Uveitis, Posterior Uveitis, Intermediate Panuveitis

Start date: 2007-01-01
Primary completion: 2008-11-01
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.